Reversible lesion of the corpus callosum associated with COVID-19: A case report
| dc.contributor.author | Gemici, YI | |
| dc.contributor.author | Tasci, I | |
| dc.date.accessioned | 2025-04-10T10:30:26Z | |
| dc.date.available | 2025-04-10T10:30:26Z | |
| dc.description.abstract | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may affect the central nervous system and peripheral nervous system. Major central nervous system manifestations of SARS-CoV-2 infection include seizures, meningoencephalitis, ischemic stroke, anosmia, and hypogeusia. The reversible splenial lesion syndrome was first described in 2004. Although reversible splenial lesion syndrome was initially recognized as a benign phenomenon, a second type of reversible splenial lesion syndrome was identified in later years, which has a poorer prognosis and potentially serious sequela. Reversible splenial lesion syndrome can be caused by numerous etiologies including viruses. In this report, we present a rare case of COVID-19 with reversible splenial lesion, who presented with ataxia and dizziness. | |
| dc.identifier.issn | 1823-6138 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14701/37042 | |
| dc.language.iso | English | |
| dc.title | Reversible lesion of the corpus callosum associated with COVID-19: A case report | |
| dc.type | Article |